Full-size annual and quarterly year-over-year growth charts for revenue, EPS, operating cash flow, EBITDA, and free cash flow against the 15%, 20%, and 30% bars over 3-, 5-, and 10-year windows, with each metric's valuation multiple vs its own history.
Revenue · 10YDoes not currently clear the 15%+, 20%+, or 30%+ revenue bars over 10Y.
Annualized revenue (TTM) · by quarter, last 40
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
| Metric | 10Y CAGR | Median YoY | YoY σ | Qtrs ≥ 20% | Neg. qtrs |
|---|---|---|---|---|---|
| RevenueRevenue | 2.7% | 3.6% | 6.2pp | 0 of 40 | 10 |
| EPSEPS | -8.2% | 9.6% | 134.5pp | 16 of 40 | 17 |
| Op cash flowOperating cash flow | 1.9% | -2% | 58.1pp | 8 of 39 | 21 |
| EBITDAEBITDA | -6.5% | 10.3% | 84.4pp | 16 of 38 | 16 |
| FCFFree cash flow | 3.9% | 1.1% | 2722.2pp | 11 of 39 | 19 |
Reported figures over 10Y: annual-series CAGR, median and standard deviation (σ, percentage points) of quarterly year-over-year growth, quarters at or above 20%, and quarters with negative YoY. “—” means the window needs more comparable data.
Scores, qualification bars, and the 0–100 consistency methodology are documented on the compounders list page →
See also: MDLZ on the compounders surface · All compounders, ranked